Bantis, Athanasios <br/><br/>
Bisphosphonate-induced osteonecrosis of the jaw in patients with bone metastatic,  hormone-sensitive prostate cancer.  Risk factors and prevention strategies.  [electronic resource] 

 -  Tumori   
 - 479-83 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2038-2529 
<br/><br/><label>Standard No.: </label>10.1177/030089161109700411  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Bisphosphonate-Associated Osteonecrosis of the Jaw--diagnosis<br/>Bone Density Conservation Agents--administration & dosage<br/>Bone Neoplasms--diagnostic imaging<br/>Diphosphonates--administration & dosage<br/>Drug Administration Schedule<br/>Humans<br/>Imidazoles--administration & dosage<br/>Infusions, Intravenous<br/>Magnetic Resonance Imaging<br/>Male<br/>Prostatic Neoplasms--pathology<br/>Radionuclide Imaging<br/>Radiopharmaceuticals<br/>Technetium Tc 99m Medronate<br/>Tomography, X-Ray Computed<br/>Zoledronic Acid